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O B J E C T I V E S The purpose of this study was to evaluate the feasibility of noninvasive imaging of
angiotensin II (AT) receptor upregulation in a mouse model of post-myocardial infarction (MI) heart failure (HF).
B A C KG ROUND Circulating AT levels do not reﬂect the status of upregulation of renin-angiotensin
axis in the myocardium, which plays a central role in ventricular remodeling and evolution of HF after
MI. Appropriately labeled AT or AT receptor blocking agents should be able to speciﬁcally target AT
receptors by molecular imaging techniques.
METHOD S AT receptor imaging was performed in 29 mice at various time points after permanent
coronary artery ligation or in controls using a ﬂuoresceinated angiotensin peptide analog (APA) and
radiolabeled losartan. The APA was used in 19 animals for intravital ﬂuorescence microscopy on a
beating mouse heart. Tc-99m losartan was used for in vivo radionuclide imaging and quantitative
assessment of AT receptor expression in 10 mice. After imaging, hearts were harvested for pathological
characterization using confocal and 2-photon microscopy.
R E S U L T S No or little APA uptake was observed in control animals or within infarct regions on days 0 and
1. Distinct uptake occurred in the infarct area at 1 to 12 weeks after MI; the uptake was at maximum at 3
weeks and reduced markedly at 12 weeks after MI. Ultrasonographic examination demonstrated left
ventricular remodeling, and pathologic characterization revealed localization of the APA tracer with
collagen-producing myoﬁbroblasts. Tc-99m losartan uptake in the infarct region (0.524  0.212% injected
dose/g) increased 2.4-fold as compared to uptake in the control animals (0.215  0.129%; p  0.05).
CONC L U S I O N S The present study demonstrates the feasibility of in vivo molecular imaging of AT
receptors in the remodeling myocardium. Noninvasive imaging studies aimed at AT receptor expression
could play a role in identiﬁcation of subjects likely to develop heart failure. In addition, such a strategy
could allow for optimization of anti-angiotensin therapy in patients after MI. (J Am Coll Cardiol Img
2008;1:354–62) © 2008 by the American College of Cardiology Foundation
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355t is well established that myocardial, more so
than the systemic neurohumoral upregulation,
contributes to ventricular remodeling and de-
velopment of heart failure (HF) after myocar-
ial infarction (MI) (1). In particular, myocardial
ngiotensin II (AT) type-1 receptor expression is
ssociated with interstitial fibrosis and ventricular
ysfunction (2). Transgenic mice with deficient
T type-1 receptor expression exhibit minimal
See page 363
eometric and structural remodeling following MI,
nd show lesser upregulation of fetal genes, trans-
orming growth factor beta-1, and collagen depo-
ition in comparison with the wild-type animals (3).
linical use of angiotensin-converting enzyme
ACE) inhibitors and angiotensin receptor blockers
n MI retards ventricular remodeling, delays devel-
pment of HF, reduces rehospitalization for wors-
ning of HF, and improves survival (4–8).
Because myocardial neurohumoral upregulation
s associated with ventricular remodeling, we hy-
othesized that a novel diagnostic strategy targeted
t detecting the extent of myocardial AT receptor
xpression would allow identification of patients
t risk of developing HF. In addition, such a
trategy should allow optimization of pharmaco-
ogic therapy in HF patients. Because subcellular
rocesses are amenable to noninvasive molecular
maging techniques, we labeled an angiotensin
eptide analog (APA) with a fluorescent tracer.
he APA targeted both angiotensin type-1 and
2 receptors with high affinity (Ki  3 pmol/l),
nd optical imaging was performed to determine
he myocardial upregulation of AT receptors after
I in an experimental mouse model. To more
pecifically target AT type-1 receptors, we also
adiolabeled losartan, a commonly used AT
ype-1 receptor blocker, and performed imaging
ith micro–single-photon emission computed
omograpy and micro-computed tomography.
Table 1. Optical and Nuclear Imaging Groups and Timeline of Im
Tracer Probe
Control
Mice
0
days
1
day
GFP APA 3 3 3
99mTc Losartan 6APA  angiotensin peptide analog; GFP  green ﬂuorescent protein; MI  myocarETHODS
he present study was performed in 29 mice (Table
). Of these, 19 mice were studied with fluorescent
PA; 16 mice were imaged up to 12 weeks after MI
nd compared with 3 noninfarcted control animals.
or radionuclide imaging, technetium-99m (99mTc)
osartan was used in 4 mice 3 weeks after MI and 6
oninfarcted control animals (Table 1). Echocardi-
graphy was performed for the assessment of left
entricular (LV) dimensions and function in all
ice prior to optical imaging. Optical imaging was
erformed in open chest preparation. Noninvasive
adionuclide imaging was performed on mice by
icro-single-photon emission computed tomogra-
hy (SPECT)/micro-computed tomography (CT)
oregistration. All animals were sacrificed after
ptical or nuclear imaging. The myocardial spec-
mens from animals receiving the fluo-
escent tracer were characterized histo-
ogically by localizing the injected probe
ith confocal and 2-photon microscopy
n frozen samples as well as by hematox-
lin and eosin staining of paraffin-
mbedded tissue. Myocardial specimens
btained from animals after nuclear im-
ging were used to determine quantita-
ive uptake of radiolabeled losartan in
he myocardium. All experiments were
pproved by the Institutional Animal
are and Use Committee at the Univer-
ity of California, Irvine and were con-
ucted in accordance with U.S. guide-
ines on the humane care and use of
esearch animals.
ynthesis of ﬂuorescein APA for optical imaging. The
eptidyl resin H-Arg(Pmc)-Val-Tyr(tBu)-Ile-
is(Trt)-Pro-Ile-R was synthesized on an Applied
iosystems 433A peptide synthesizer (Applied
iosystems, Foster City, California) starting with
moc-Ile-Wang resin. The N-terminus was bro-
oacetylated using bromoacetic anhydride. The
romoacetylated peptidyl resin was then treated
ing
Post-MI Mice
Total
1
week
3
weeks
6
weeks
12
weeks
3 3 3 1 19
4 10
A B B
A N D
ACE
enzym
APA
analo
AT
CT
HF
LV
MI
SMA
SPECT
compagdial infarction; 99mTc  technetium-99m.R E V I A T I O N S
A C R O N YM S
angiotensin-converting
e
angiotensin peptide
g
angiotensin II
computed tomography
heart failure
left ventricle
myocardial infarction
smooth muscle actin
 single-photon emission
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356ith N-Boc-ethylenediamine. The simultaneous
emoval of protecting groups and cleavage of the
eptide from the resin was carried out in triflu-
roacetic acid. Subsequently, trifluoroacetic acid
as removed in vacuo, diethyl ether added to
he residue, and the precipitated peptide washed
ith diethyl ether and dried. The crude pep-
ide, fluorescein N-hydroxysuccinimide ester,
nd N-methylmorpholine were dissolved in
imethylformamide-affording fluorescein APA
Fig. 1A). The reaction product was purified by
reparative reversed-phase high performance liq-
id chromatography. The pure fluorescein APA
as analyzed by analytical high performance
iquid chromatography and electrospray mass
pectrometry.
ynthesis of chelate-coupled losartan-Leu-Diglycoloyl-
EG(4)-Tetraamine and radiolabeling. The optimal
harmacokinetic profile of an imaging agent differs
adically from therapeutic drugs in that rapid excre-
ion from blood is advantageous. Because peptides
re particularly better suited for targeting in vivo
ue to a superior biodistribution profile, we intro-
uced peptide characteristics into the losartan phar-
acophore. To facilitate a convenient and rapid
ynthesis, we adopted a solid phase approach where
osartan was immobilized on a trityl resin through
ts tetrazole group. Further replacement of the
ydroxyl group by an amino group enabled attach-
ent of amino acids, linkers, and tetracycline che-
ates by standard peptide synthesis methods. This
trategy did also increase the affinity of losartan for
T type-1 receptors. Structure activity data showed
Figure 1. Structure of Tracers Used for AT Receptor TargetingFluorescent angiotensin peptide analog (APA) (A), technetium Tc-99m lhat the introduction of the amino acid leucine and
short linker comprising tetraethylene glycol and
iglycolic acid between the losartan moiety and the
etra-amine chelate yielded a losartan analog (Fig.
B) with superior affinity (Ki  60 pmol/l) to AT
eceptors compared with losartan (Ki  10 nmol/l)
nd an acceptable biodistribution profile with
ainly urinary excretion.
ouse model of HF. Male Swiss Webster mice
weight 20 to 30 g, Charles River, Wilmington,
assachusetts) were anesthetized with pentobarbi-
al (75 mg/kg by intraperitoneal injection) and
ntubated with a 21-G tube for mechanical venti-
ation. The electrocardiogram was monitored con-
inuously, and body temperature was maintained
hroughout the procedure at 36.5°C. Ventilation
as maintained at a 250-l tidal volume and a
espiratory rate of 200 breaths/min (MiniVent
SE-HA, Harvard Apparatus, Holliston, Massa-
husetts). The heart was exposed through the
ourth left intercostal thoracotomy, and the left
oronary artery was ligated at its second branching
oint with a 6-0 Prolene suture. After watching the
nimal carefully for 30 min, the chest was closed
sing a 6-0 Monocryl suture. The animals were
ubjected to optical or radionuclide imaging at
arious time points in follow-up. Before imaging,
nesthetized animals were examined by transtho-
acic echocardiography using a 14-MHz linear
robe (Acuson 15L8, Siemens, Malvern, Pennsyl-
ania). B-mode images of LV parasternal long axis
nd short axis were obtained and digitally analyzed
s described previously (9).osartan (B). AT  angiotensin II.
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357ptical imaging using ﬂuorescent APA. Frozen dried
liquot (100 g) of the compound was dissolved in
00 l of distilled water. After cannulation of the
nternal jugular vein, 50 g of fluorescent APA was
njected. Real-time optical imaging was performed
rom baseline to 30 min as previously described (10)
sing a fluorescence stereomicroscope (Leica
Z16FA, Leica Microsystems, Heerbrugg, Swit-
erland) equipped with a charge-coupled device
amera (Orca 285, Hamamatsu, Japan). A 470/
0-nm bandpass excitation filter was used, and
mitted fluorescence was collected through a band-
ass filter of 525/50 nm. Images were analyzed
sing SimplePCI software (Compix, Sewickley,
ennsylvania). In vivo optical imaging was per-
ormed on the day of MI, 30 min after coronary
igation (n  3); day 1 (n  3); and weeks 1 (n  3),
(n  3), 6 (n  3), and 12 (n  1) after MI in
pen-chested mice. Fluorescence APA imaging was
lso performed in 3 unmanipulated control mice.
adionuclide imaging using radiolabeled losartan.
adiolabeled losartan was used in 4 mice, 3 weeks
fter MI and 6 unmanipulated age-matched control
ice, using a dual-head micro-SPECT gamma
amera and a micro-CT (X-SPECT, Gamma
edica, Northridge, California). The SPECT im-
ges were acquired in a 64  64 matrix, 32 steps at
0 s (0 h) or 120 s (at 4 h) per step at 140-KeV
hotopeak of 99mTc-losartan with a 15% window
sing a low-energy, high-resolution parallel colli-
ator. The CT images were acquired without
oving the animals. The micro-CT uses an X-ray
ube operating at 50 kVp and 0.6 mA, with images
aptured for 2.5 s per view for 256 views in 360°
otation. Micro-CT images were transferred to a
56  256 matrix and micro-CT tomographic
tudies were fused, facilitating scintigraphic and
natomic information in all tomographic scans in 3
patial axes. Animals were killed by an overdose of
entobarbital (120 mg/kg) after the imaging exper-
ments. Hearts were carefully extracted and planar
mages of ex vivo heart were acquired for 15 min in
128  128 matrix using a low-energy, high-
esolution, pinhole collimator. Thereafter, each
eart was cut into 3 bread-loaf slices (infarct,
eri-infarct, and remote areas). The quantitative
adiolabeled losartan uptake was determined with a
amma scintillation counter (1480 Wizard 3-inch;
allac Co., Turku, Finland).
athologic characterization of the myocardial tissue.
earts harvested after the optical imaging experi-
ents were used for histopathologic characteriza-
ion taking advantage of the intravenously admin- hstered fluorescent AT receptor probe. For this
urpose, half of the myocardial tissue specimens
ere snap-frozen. Frozen sections (7 m) of the
eart were cut and examined by confocal micros-
opy (Axioplan 2, Zeiss, Göttingen, Germany)
irectly without further preparation. Subsequently,
he same myocardial tissue specimens were stained
ith -smooth muscle actin (SMA) antibody
Sigma, St. Louis, Missouri) for localization of
yofibroblasts. The antibody for SMA was conju-
ated to a rhodamine-linked secondary antibody.
ndividual localization of APA and SMA were
egistered and merged subsequently to investigate
olocalization. To further characterize cellular APA
ptake, the infarcted myocardial region was also
nalyzed by 2-photon microscopy. This imaging
etup consisted of a mode-locked Ti:Sapphire laser
170-fs pulse width, 76 MHz repetition rate; Mira
00F, Coherent Radiation, Palo Alto, California)
umped by a 5-W Verdi laser (Coherent Radia-
ion). The 800-nm wavelength excitation beam
as deflected into the back port of an inverted
xiovert 100 microscope (Zeiss) and scanned across
he sample by a personal computer– controlled
alvanometer-driven x-y scanner (Series 603X,
ambridge Technology, Watertown, Massachu-
etts). The beam was then reflected by a short-pass
75-nm dichroic beam splitter (Chroma Technol-
gy, Brattleboro, Vermont) and focused onto the
ample with a 63, water-immersion microscope
bjective (C-Apochromat, numerical aperture 
.2, Zeiss). The average excitation power entering
he microscope was approximately P  60 mW
corresponding to 5 mW at the sample site). The
uorescence and second harmonic generation sig-
als from the sample were discriminated by a
75-nm short-pass dichroic mirror, transmitted
hrough a short-pass 600-nm filter (CVI Laser,
ivermore, California), and further split by second-
ry long-pass 510-nm dichroic mirror onto 2 pho-
omultiplier tubes with narrow (10-nm bandwidth)
andpass 400-nm filter (Chroma Technology) for
econd harmonic generation collection and 535-nm
50-nm bandwidth) band-center filter (Chroma
echnology) for green fluorescence collection. Im-
ges (256  256 pixels) were taken at various
epths (z), covering an area of 35  35 m2 for the
3 microscope objective. Each acquisition was
ntegrated for 10 s. The remaining half of the
yocardial tissue specimens were fixed with 4%
hosphate-buffered paraformaldehyde; fixed myo-
ardial tissue specimens were analyzed routinely by
ematoxylin and eosin staining.
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358tatistical analysis. All quantitative results are pre-
ented as the mean  SD. To determine statistical
ignificance of differences, Mann-Whitney test was
sed and a p value smaller than 0.05 was considered
ignificant.
E SULTS
eal-time optical imaging of myocardial angiotensin
eceptors in HF. Optical imaging was performed
ith fluoresceinated APA. Although all infarcts
ere non-reperfused, the tracer entry in the in-
arcted myocardium occurred within 3 min and
aximized in 20 min (Figs. 2A to 2D). In addition
o myocardial localization, coronary arteries and
rterioles showed intense uptake of the ligand; the
Optical Imaging of AT Receptors
icroscopy images show a 3-week old MI in the murine heart
del from baseline (A), and 3 min (B), and at 20 min (C) after
tion of green ﬂuorescent angiotensin peptide analog (APA), dem-
gradual increase of the ﬂuorescent APA in infarcted region. Fluo-
take was maximized at 20 min after intravenous APA injection.
o image (D), demonstrates APA uptake in the border zone, as
t infarct zone has collapsed and is therefore not visible. Panel E
uptake in smooth muscle cell layer of a small coronary artery
rrows) as well as minimal uptake in thinner veins (diagonaldptake was minimal in the venous tree (Fig. 2E).
o uptake of fluorescent APA probe was observed
n the infarct area immediately after MI and 1 day
fter MI. However, distinct APA uptake was ob-
erved in the infarct regions at 1 week following
I, which increased substantially by 3 weeks (Fig.
A). Minimal uptake of fluorescent probe was
bserved in the remote areas. Subsequently, the
ptake in infarct region decreased at 6 weeks after
I and was predominantly seen in the infarct
order zone (Fig. 2D). Uptake resolved by the 12th
eek. Echocardiographic examination demon-
trated left ventricular dilation over time indicating
rogressive cardiac remodeling (Fig. 3B). Unma-
ipulated control animals receiving fluorescent
PA did not show tracer uptake (Fig. 3A).
athologic characterization of receptor targeting. Di-
ect localization of systemically administered fluo-
escent APA probe allowed characterization of
inding sites of AT receptors in the myocardial
issue specimens. The APA uptake (green, Figs. 4A
nd 4B) was almost exclusively localized in cells
ther than cardiomyocytes. The fluorescently la-
eled cells in the replacement fibrosis in infarcted
nd peri-infarcted regions (green, Fig. 4D) stained
ositively for -SMA (red, Fig. 4E). These data
uggest that binding of the APA occurs, at least in
large part, to myofibroblasts (yellow, Figs. 4D to
F). Although no uptake was seen in the cardio-
yocytes, endothelial cells, or interstitial cells, APA
ptake was distinctly observed in the vascular me-
ial layers in arterioles. Two-photon microscopy
evealed internalization of the green APA probe
ithin the myofibroblasts and demonstrated intra-
ellular and nuclear localization of the APA (Fig.
C). Using second harmonic generation imaging,
ollagen fibers (blue) were seen emanating from the
PA-positive cells, which further suggests the
yofibroblastic origin of these cells (Fig. 4C).
uclear imaging of angiotensin receptors. For nonin-
asive imaging of angiotensin receptors, we used
adiolabeled losartan, in the 3-week post-MI ani-
als for micro-SPECT/micro-CT imaging; a
-week post-MI model was chosen for radionuclide
maging because of maximal upregulation of AT
eceptors observed in the optical imaging experi-
ents. Radiolabeled losartan uptake was compared
ith unmanipulated control animals (Fig. 5). The
ombination of micro-SPECT and -CT images
llowed for precise localization of myocardial up-
ake, which was observed in the anterolateral car-
iac region. Ex vivo imaging of the explanted heartsFigure 2.
Intravital m
failure mo
administra
onstrating
rescent up
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359erritory (Fig. 5C). Quantitative radiotracer uptake
n infarcted myocardium, represented as percentage
f injected radiotracer uptake per gram of myocar-
ial tissue, was significantly higher than in control
earts (0.52  0.21% vs. 0.21  0.13%, p  0.05).
he mean infarct-to-remote region uptake ratio
as 2.4:1. The maximum non-target organ radia-
ion burden was observed in liver and kidney.
I SCUS S ION
he pivotal role of the renin-angiotensin system
n ventricular remodeling following MI has been
stablished in numerous experimental and clinical
tudies. More than circulating renin-angiotensin
evels, it is the myocardial upregulation of ACE,
T and its receptors, which determine the like-
ihood of ventricular remodeling (3,11). As such,
he use of angiotensin receptor blockers (6,12)
nd ACE inhibitors (13–15) has resulted in
mproved survival in patients with manifest and
ubclinical HF. It has been suggested that max-
mization of anti-angiotensin therapy, including
Figure 3. Evolution of APA Uptake After MI
Intravital microscopy images demonstrating uptake of ﬂuorescent A
and 12 weeks after MI (A). The uptake increases from 1 to 3 weeks
grams at 1, 3, and 12 weeks, indicating left ventricular dilation andncrease in ACE-inhibitor dose or addition of Angiotensin receptor blockers over ACE-inhibitor
herapy further reduces morbidity (6,16) and
ortality (4) in HF. It is therefore conceivable
hat accurate assessment of myocardial AT recep-
or expression should guide optimization of anti-
ngiotensin therapy. It should also allow periodic
valuation of the efficacy of anti-angiotensin
ntervention. Current diagnostic imaging of HF
emains generally focused on geometric and
tructural cardiac alterations (17,18), and it can
e hypothesized that the ability to visualize
nterstitial processes at the molecular level, which
recede the geometric and functional deteriora-
ion of the left ventricle, should help predict the
ikelihood and rate of remodeling and develop-
ent of HF (19).
The present study demonstrates the feasibility of
n vivo imaging of myocardial angiotensin receptors
n an experimental HF model. Currently, as a
trategy for prevention of advanced HF, significant
mphasis is being placed on the recognition of
atients at risk for developing HF, including those
ith no apparent structural LV abnormality (stage
from 6 groups: no infarction, and 0 day, 1 day, 1 week, 3 weeks
decreases thereafter. Panel B shows the respective echocardio-
gressive heart failure in these mice with MI.PA
, and) and asymptomatic patients with a known struc-
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360ural LV abnormality (stage B) (20). As the current
linical practice allows diagnosis of HF only after
he LV has undergone substantial remodeling, de-
elopment of a technology that actually predicts
ccurrence of cardiac remodeling is of critical im-
ortance. Our immunohistochemical analyses show
hat binding of the tracer uptake was almost exclu-
ively localized to myofibroblasts; we did not ob-
erve APA uptake in cardiomyocytes. Upregulation
f AT receptors on myofibroblasts (Fig. 4F) allows
Figure 4. Pathologic Characterization APA Localization
The remote zone (A) demonstrates no APA uptake in interstitium (*
strate ﬂuorescent APA uptake in the infarct zone (B), with an enlarg
(D, green) also stained positively for smooth muscle actin (SMA) (E
(ATR) on myoﬁbroblasts. (C) Ex vivo 2-photon microscopy demonst
with collagen surrounding the myoﬁbroblast using second harmoni
Figure 5. Noninvasive Imaging of AT Receptors With Radiolabe
The micro–SPECT and micro-CT images are shown in a control mou
heart can be seen (A) in the in vivo and ex vivo images. There is on
the 3-week post-MI animal, signiﬁcant radiolabeled losartan uptake
the in vivo image is conﬁrmed in the ex vivo image. The histogram
region (0.524  0.212% ID/g) as compared to control noninfarcted animor growth factor (such as AT)–induced myofibro-
last proliferation and collagen production, which is
elieved to contribute to healing and the remodel-
ng process following MI (2,21,22). Although an-
iotensin receptor upregulation in the kidneys has
een observed earlier by a carbon-11 labeled AT
ype-1 antagonist (23), the hypothesis of the role of
argeting neurohumoral upregulation for ventricular
emodeling has been supported by imaging of
enin-angiotensin axis with the help of radiolabeled
cardiomyocytes (arrows). The cells of nonmyocytic origin demon-
image of cellular uptake (inset). These cells in the infarct region
), showing colocalization (F, yellow), indicating AT receptors
ﬂuorescent APA intracellularly within the myoﬁbroblast (green),
neration imaging (blue). Abbreviations as in Figure 1.
Losartan
fter technetium Tc-99m losartan administration; no uptake in the
ome liver uptake on the bottom left of the SPECT image. (B) In
bserved in the anterolateral wall (arrows). The infarct uptake on
demonstrates signiﬁcantly (*) higher uptake in the infarcted) or
ed
, red
ratedled
se a
ly s
is o
(C)als (0.215  0.129% ID/g; p  0.05). ID  injected dose.
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361enzoyl lisinopril (21,24). Dilsizian et al. (24)
ncubated myocardial specimens explanted from
atients undergoing cardiac transplantation for
nd-stage ischemic cardiomyopathy with F-18
uoro-benzoyl lisinopril. There was specific bind-
ng of radiotracer to ACE; mean binding was 6.6
.2, compared with 3.4 2.5 luminescence/mm2 in
egments pre-incubated with cold lisinopril (p 
.0001). Further, mean radiotracer binding was 6.3
4.5 in infarcted, 7.6  4.7 in peri-infarcted, and
.0  1.0 luminescence/mm2 in remote non-
nfarcted (p  0.02) segments. The distribution of
ast cell chymase was nonuniform in these samples
nd disparate from ACE. This and the study
resented here demonstrate that ACE (and proba-
ly AT) upregulation induces the proliferation of
yofibroblasts (which have increased angiotensin
eceptor density) and contributes to collagen depo-
ition. Both studies have also demonstrated that
hese key steps in the tissue renin-angiotensin
ascade involve receptor upregulation of only about
- to 3-fold. It therefore remains to be seen whether
maging targeted to AT receptors and/or ACE willGroup. Effects of enalapril on mortal- OPTIMAAL randONCLUS IONS
he present study explains the development of a
iagnostic probe seeking AT receptor upregula-
ion within the myocardium and shows the fea-
ibility of noninvasive radionuclide imaging. The
uorescent angiotensin receptor probe confirms
eceptor localization on myofibroblasts, which
ay contribute to the process of interstitial fibro-
is. It is proposed that monitoring of angiotensin
eceptor expression after infarction may predict
he evolution of HF. The present study offers a
roof of concept, with modest uptake of radiola-
eled losartan and it will be necessary to engineer
robes with better targeting characteristics for
ealization of potential clinical application.
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